Second Opinion - Immunotherapy In Cancer Treatment

Despite his initial prognosis of six to eight months to live, Ronald Eckert, MD, is thriving after undergoing a new immunotherapy treatment for stage 4 melanoma. Four years after the treatment, he feels he is cured and shares his story. Medical experts discuss the groundbreaking immunotherapy research and treatments being discovered each day in the area of cancers-treatments that will change the way we look at cancer.

Series Website:

Recent and Upcoming Airings

11.2 1/29 5:00 am 11.2 1/29 10:30 am 11.2 2/3 12:30 pm